Expanding

• NanoViricides will begin a clinical trial next week for the oral drug NV-387 to treat an expanding Ebola outbreak in the Democratic Republic of Congo. • The current outbreak of the Bundibugyo Ebolavirus variant has a 48% crude fatality rate and no approved treatment or vaccine. • The virus has spread into displacement camps hosting over 4.4 million people, creating a high-risk population with poor sanitation and medical resources.

• European stock markets declined recently as investors reacted to an expanding conflict in the Gulf and anticipated an upcoming Federal Reserve meeting. • Market participants are monitoring price movements and data provided by market makers, though these indicative prices may differ from actual exchange rates. • This volatility creates uncertainty for traders and investors who must balance geopolitical risks against potential U.S. interest rate decisions.

Changes include fewer seats in parliament and new rules on presidential candidates ahead of December electionsGuinea-Bissau voters have approved a new constitution significantly expanding presidential powers ahead of elections due in December.According to provisional results, 70% of voters approved sweeping changes in the tiny west African state’s first constitutional amendment since revisions that ended the one-party socialist state more than three decades ago. Continue reading...

• OpenAI is expanding its ChatGPT advertising footprint to 31 European countries starting next week. • The rollout includes major markets such as Germany, France, Spain, Italy, Sweden, Norway, Denmark, the Netherlands, and Austria. • This expansion provides advertisers with a new high-intent channel to reach users within the AI interface.

• NanoViricides, Inc. (NYSE American: NNVC) announced on August 18, 2026, that it will soon begin a Phase II clinical trial for NV-387 oral gummies. • The trial aims to treat the Bundibugyo Ebola virus during what is described as the largest and most rapidly expanding outbreak to date in the Democratic Republic of Congo. • This development is critical as the company seeks to provide an accessible, antiviral treatment that prevents viral escape during a major public health crisis.

• OpenAI has announced the expansion of its ChatGPT Ads service and product to 31 European countries. • The rollout includes major markets such as Germany, France, Spain, Italy, Sweden, Norway, Denmark, the Netherlands, and Austria. • This move signifies a strategic push to monetize the platform and integrate advertising capabilities within the European regulatory landscape.

• NanoViricides has received regulatory approval to launch a Phase II clinical trial for NV-387 oral gummies to treat Ebola in the Democratic Republic of Congo. • The trial aims to combat the current outbreak, which is described as the largest and most expanding in the region's history. • Led by Professor Katoto and supported by experts like Fogarty Fellow Patrick, the study leverages specialized implementation research networks to scale novel treatments.

• NanoViricides, Inc. (NYSE American: NNVC) received regulatory approval on August 10, 2026, to launch a Phase II clinical trial for its NV-387 oral gummies. • The trial will take place in the Democratic Republic of Congo to treat patients affected by the current largest and most rapidly expanding Ebola outbreak. • This development is critical as the company aims to provide an accessible, antiviral treatment designed to prevent viral escape during a public health crisis.

• NanoViricides has received regulatory approval to launch a Phase II clinical trial for NV-387 oral gummies, designed as a treatment for the Ebola virus. • The trial will take place in the Democratic Republic of Congo to combat the largest and most rapidly expanding Ebola outbreak on record. • The urgency for the treatment is heightened by the virus spreading into displacement camps housing over 4.4 million people, where poor sanitation and medical resources increase risk.

• The US Supreme Court concluded its term with a series of rulings that provided significant advantages to Donald Trump and the Republican Party. • The court loosened campaign finance restrictions and spending limits, potentially benefiting the GOP, which holds over $125 million compared to a debt-ridden Democratic Party. • In April, six conservative justices struck down a key provision of the 1965 Voting Rights Act, ruling that congressional districts designed to increase minority voting power are unconstitutional.

• InCorp reports that AI is rapidly evolving the cybersecurity landscape, creating a "new reality" where businesses must balance technological opportunities against increasingly sophisticated threats. • The report highlights a critical vulnerability in vendor exposure, noting that cybersecurity has become a fundamental trust issue between companies and their clients. • Data shows that 65% of consumers immediately lose trust in a brand following a security breach, with recovery of that confidence taking significantly longer than the incident resolution.

• The European Union is approaching key implementation deadlines for the EU AI Act, creating significant regulatory hurdles for US-based AI startups expanding into Europe. • Industry specialists warn that the Act's strict compliance requirements and potential penalties may deter American innovation and limit the availability of advanced AI tools within the EU. • This regulatory shift matters as it establishes a global benchmark for AI governance, forcing companies to balance rapid development with rigorous safety and transparency standards.

• Germany has approved a draft law expanding the cyber defense powers of the Federal Office for Information Security (BSI), the Federal Criminal Police Office (BKA), and the Federal Police. • The legislation authorizes these agencies to actively disrupt attacker infrastructure, including the ability to target systems located outside of German borders. • This move follows documented sustained cyber campaigns targeting government bodies, political parties, research institutions, and industrial companies, some of which are linked to state-affiliated actors.

• On May 25, 2026, India's startup ecosystem saw significant growth across diverse sectors, highlighted by Yes Madam securing Rs 50 crore in new funding. • Key expansions include the entry of Voy into the Indian market, Graamya's rural spice initiatives in Kerala, and the launch of a Quantum AI lab in Mysuru. • The day also marked advancements in deep-tech and the creator economy, alongside the introduction of new maritime research projects at IIT Madras.

• Fred Hutch Cancer Center in Seattle announced recent research findings on May 6, 2026, addressing multiple areas including improved outcomes for stem cell transplants and newly explored connections between solar jetlag and liver cancer development. • The research represents efforts to expand the range of cancer treatment targets beyond conventional approaches, with implications for patient outcomes across multiple cancer types. • These findings contribute to the broader understanding of both cellular and environmental factors influencing cancer development and treatment efficacy, potentially informing new therapeutic strategies.

The Israeli military began carrying out strikes in eastern Lebanon on Monday, expanding the scope of its bombing campaign during a ceasefire that has failed to fully halt hostilities with Lebanese armed group Hezbollah.

Pyongyang making ‘very serious’ progress on producing weapons, with rapid rise in activity at main nuclear complexNorth Korea has made “very serious” progress in its ability to produce more nuclear weapons, the head of the UN’s nuclear watchdog has warned, in another sign that the regime is seeking to use its nuclear arsenal to ensure its survival.North Korea is thought to have assembled about 50 nuclear warheads, although some experts are sceptical of its claims that it is able to miniaturise them so they can be attached to long-range ballistic missiles. Continue reading...

• HHS issued a final rule on April 7, 2026, permanently extending Medicare telehealth flexibilities introduced during COVID-19, covering 85 million Medicaid enrollees. • Audio-only visits now reimbursable at $18-$40 per session, with $37 billion allocated through 2030 to rural providers. • Addresses access gaps in 20% of US counties lacking specialists; 'This bridges urban-rural divides,' said HHS Secretary.

Scientific advisory committee to examine impact of offering routine MenB jabs to wider range of peopleThe Kent meningitis outbreak: what is happening and why?Experts are considering expanding the meningitis B vaccination eligibility in response to the fatal outbreak of the disease in Kent.The Joint Committee on Vaccination and Immunisation’s review comes after the health secretary, Wes Streeting, asked it to to “re-examine eligibility for meningitis vaccines” for a wider range of people than those who currently qualify. Continue reading...

• The State Department announced on March 18 that effective April 2, 2026, citizens from 12 additional countries—Cambodia, Ethiopia, Georgia, Grenada, Lesotho, Mauritius, Mongolia, Mozambique, Nicaragua, Papua New Guinea, Seychelles, and Tunisia—must post bonds of up to $15,000 when applying for U.S. visas. • After April 2, the total number of countries subject to the visa bond requirement will expand to 50, primarily targeting nations with high overstay rates, particularly in Africa; visa applicants must post bonds ranging from $5,000 to $15,000 depending on their circumstances and consular officer discretion. • The Trump administration program, rolled out last year to combat visa overstays and illegal migration, has demonstrated effectiveness, with the State Department reporting that nearly 97% of almost 1,000 bond-posting applicants have not overstayed their visas.